Association for Molecular Pathology                       
Newsletter                                                                
   
May 2009, Volume 15, Number 2 

Inside this Issue

Front Page
President's Message
Committee Reports
• Clinical Practice Committee
• Economic Affairs Committee
• Membership & Professional
  Development Committee

• Nominating Committee
• Professional Relations Committee
• Program Committee
• Publications Committee
• Training & Education Committee
Subdivision Reports
• Genetics
• Hematopathology
• Infectious Diseases
• Solid Tumors
Special Features
• AMP Leadership Award
• CHAMP

• Member Survey Report
• Web Editorial Board Report
• Show Me the Money!
• Announcements
• Career Opportunities
• Meetings and Upcoming Events
2009 AMP Officers and Appointees

Member Survey Report - Demographics

Geography: 89% of respondents are in the U.S.; 3% in Canada; other respondents are in Belgium, Chile, Germany, Greece, Hong Kong, India, Italy, Korea, Norway, Singapore, Sweden, The Netherlands.  Two respondents identified their work location as global or worldwide.  Most U.S. respondents are in California (7%), Pennsylvania (8%), and Texas (7%).  Every single member in Alabama must have answered the survey; either that, or a few people took the survey multiple times – what a way to get your voices heard!  No one answered the survey from Delaware, Hawaii, Kentucky, Nevada, South Dakota, or Vermont.  We do not have any members in Idaho, Mississippi, or Wyoming.

Longevity of AMP Membership: more than 10 years (16%), 8-10 years (12%), 4-7 years (37%), 1-3 years (27%), less than 1 year (8%).

Highest Academic Degree attained by respondents was pretty evenly split between PhD only (39%) and MD/PhD/DO (33%).  A significant number of respondents (25%) have Bachelor’s or Master’s as the highest degree attained.

Certifications:  Approximately 25% of respondents hold AP/CP and 15% hold MGP certifications from ABP; 18% hold certification from ABMG; 17% CLSp(MB) from NCA; 15% MT from ASCP.  Eighteen other certifications are held by 1-6% of the respondents.

Specialty Areas: 53% in genetics; 41% in solid tumors; 38% in infectious diseases/microbiology; 37% in hematopathology; 21% in pharmacogenomics; 18% in basic research; 9% industry R&D; 5% forensics and identification; 5% sales/marketing; other specialty areas 1-4%.

Primary Role:  41% are Lab Director/Assoc Director; 12% physician; 9% R&D; 6% Supervisor or Technologist; other roles 1-4.

Areas of Practice: 58% genetics; 47% each hematopathology, infectious diseases, solid tumors; 25% pharmacogenomics.

Institutions: 52% academic medical center; 21% reference lab; 15% community hospital/medical center; 14% product manufacturer; 3% policy/government

Continuing Education Requirements: 59% CME; 14% Certificate of Completion (contact hours/CEUs) 

Go to:
The AMP Organization
The Annual Meeting
   Overview of Survey Responses
   Insight into Decisions – A Report from Maricel M. Herrera, CMP,   
   CEM, Director of Meetings and Membership Services

   Insight into CME – A Report from Mark Sobel